1301 - 1325 of 6568 Results
Title
Year
-
OPENTitle: Sex Differences in Brain and Cognition in de novo Parkinson's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page: 791532End Page: 791532Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.791532Best OA location URL: https://doi.org/10.3389/fnagi.2021.791532Citation Count: 41
-
OPENTitle: The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat ModelsJournal Name: BiomoleculesPublisher: MDPI AGVol: 11Issue #: 11Start Page: 1685End Page: 1685Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom11111685Best OA location URL: https://www.mdpi.com/2218-273X/11/11/1685/pdf?version=1636779345Citation Count: 8
-
OPENTitle: Silica-coated magnetic-nanoparticle-induced cytotoxicity is reduced in microglia by glutathione and citrate identified using integrated omicsJournal Name: Particle and Fibre ToxicologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page: 42End Page: 42Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12989-021-00433-yBest OA location URL: https://particleandfibretoxicology.biomedcentral.com/track/pdf/10.1186/s12989-021-00433-yCitation Count: 26
-
OPENTitle: α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controlsJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 6Issue #: 12Start Page: 2426End Page: 2436Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.50944Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.50944Citation Count: 45
-
OPENTitle: Lack of progression of beta dynamics after long‐term subthalamic neurostimulationJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 11Start Page: 2110End Page: 2120Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51463Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51463Citation Count: 33
-
OPENTitle: Serine/Threonine Protein Phosphatase 2A Regulates the Transport of Axonal MitochondriaJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page: 852245End Page: 852245Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2022.852245Best OA location URL: https://doi.org/10.3389/fncel.2022.852245Citation Count: 6
-
OPENTitle: Multivariate genomic and transcriptomic determinants of imaging-derived personalized therapeutic needs in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 5483End Page: 5483Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-09506-0Best OA location URL: https://www.nature.com/articles/s41598-022-09506-0.pdfCitation Count: 7
-
OPENTitle: Integrated Genomic, Transcriptomic and Proteomic Analysis for Identifying Markers of Alzheimer’s DiseaseJournal Name: DiagnosticsPublisher: MDPI AGVol: 11Issue #: 12Start Page: 2303End Page: 2303Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/diagnostics11122303Best OA location URL: https://www.mdpi.com/2075-4418/11/12/2303/pdf?version=1638953319Citation Count: 16
-
OPENTitle: Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cellsJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 9Start Page: 850End Page: 863Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00110-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8728893Citation Count: 54
-
OPENTitle: Structural and biochemical insights into lipid transport by VPS13 proteinsJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1083/jcb.202202030Best OA location URL: https://rupress.org/jcb/article-pdf/221/5/e202202030/1430680/jcb_202202030.pdfCitation Count: 82
-
OPENTitle: Toward a standard model for autophagosome biogenesisJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 222Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1083/jcb.202304011Best OA location URL: https://escholarship.org/uc/item/8592h4hnCitation Count: 23
-
OPENTitle: Evaluation of Compensation Strategies for Gait Impairment in Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 20Start Page: e2253End Page: e2263Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1212/wnl.0000000000201159Best OA location URL: https://n.neurology.org/content/neurology/99/20/e2253.full.pdfCitation Count: 29
-
OPENTitle: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 8Start Page: e859End Page: e871Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013218Best OA location URL: https://n.neurology.org/content/neurology/98/8/e859.full.pdfCitation Count: 198
-
OPENTitle: Disease-Modifying Antirheumatic Drugs and Risk of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 12Start Page: e1273End Page: e1281Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013303Best OA location URL: https://n.neurology.org/content/neurology/98/12/e1273.full.pdfCitation Count: 25
-
OPENTitle: Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid AngiopathyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 17Start Page: e1716End Page: e1728Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200136Best OA location URL: https://n.neurology.org/content/neurology/98/17/e1716.full.pdfCitation Count: 38
-
OPENTitle: Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 22Start Page: e2194End Page: e2203Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200113Best OA location URL: https://n.neurology.org/content/neurology/98/22/e2194.full.pdfCitation Count: 66
-
OPENTitle: Planning for Prevention of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200789Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/1.full.pdfCitation Count: 30
-
OPENTitle: What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 61End Page: 67Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200786Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/61.full.pdfCitation Count: 21
-
OPENTitle: Use of Whole-Genome Sequencing for Mitochondrial Disease DiagnosisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7Start Page: e730End Page: e742Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200745Best OA location URL: https://n.neurology.org/content/neurology/99/7/e730.full.pdfCitation Count: 67
-
OPENTitle: Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903320.23411.f9Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S40.full.pdfCitation Count: 4
-
OPENTitle: Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy ControlsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903096.36040.1dBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S8.full.pdfCitation Count: 0
-
OPENTitle: Interfacility Transfers for Seizure-Related Emergencies in the United StatesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page: e2718End Page: e2727Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201319Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9757868Citation Count: 9
-
OPENTitle: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor EncephalitisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdfCitation Count: 4
-
OPENTitle: Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S VariantJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 8Start Page: e814End Page: e823Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200737Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9484727Citation Count: 10
-
OPENTitle: Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00285-zBest OA location URL: https://www.nature.com/articles/s41531-022-00285-z.pdfCitation Count: 11